We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Expert Opinion / Interview · October 29, 2018

ESMO 2018: Contextualized Insights From ATLAS on the Use of TKIs in Adjuvant mRCC Treatment

Interview by
Benjamin L. Maughan MD, PharmD
Interview with
Sumanta Kumar Pal MD


Additional Info

Further Reading